Shorten the timeline from research to real world use.

Apply our platforms, OS-T and OS-IP, to vaccine development, therapy response, disease reccurence, and more.

Our platforms OS-T and OS-IP

OS-VAX

Comprehensive.

Accelerate vaccine development.

Learn more Order

OS-IMT

Predictive.

Identify therapy response.

Learn more Order

OS-MRD

Sensitive.

Monitor disease recurrence.

Learn more Order

OS-VAX

Order

Accelerate vaccine development.

Identify publicly conserved clonotypes, measure their activation and efficiency against disease and analyze to which epitopes it has been most commonly associated.

OS-T

and

OS-IP

Rapidly identify promising vaccine candidates.

Inform vaccine design for variants.

Detect and longitudinal track vaccine-induced immunity.

Understand breadth and durability of protective clones.

OS-IMT

Order

Improve immunotherapy.

Track immune response for immunotherapy success.

OS-T

and

OS-IP

Accelerate development of cellular medicine.

Use predictive biomarkers to optimize clinical trials and identify eligible patients.

Assess therapy efficacy by identifying clonotypes associated with therapeutic outcome.

Use AI models to predict patient reaction to therapy.

Optimise therapeutic cell design.

OS-MRD

Order

Monitor disease recurrence early.

Sensitive quantification of Minimal Residual Disease (MRD) for haematological malignancies at high resolution from blood.

OS-B

and

OS-IP

Shorten the timeline from research to real world use.

Applications

Gain a holistic view of immune system dynamics to inform vaccine development, measure therapy efficacy, and for haematological malignancies detect early traces of disease.

Comprehensive.

Predictive.

Sensitive.